Peter Dy, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Peter Dy’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$5,967
Pharmacies billed $5,967 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 28% of their Part D prescriptions (55 of 197) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%.
186 generic and fewer than 11 brand-name prescriptions · $5,967 in drug cost · 36 antibiotic prescriptions to 35 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Methenamine Hippurate | 13 | $592 | $46 |
| Gabapentin | 44 | $303 | $7 |
| Oxycodone | 44 | $204 | $5 |
| Ibuprofen | 14 | $51 | $4 |
Year by year
| 2024 | 197 | 108 | 28% (55) | None | $5,967 |
| 2023 | 208 | 100 | 26% (54) | None | $5,144 |
| 2022 | 172 | 73 | 23% (40) | 12% | $8,751 |
| 2021 | 140 | 71 | 28% (39) | 11% | $4,212 |
| 2020 | 110 | 74 | 39% (43) | None | $2,450 |
| 2019 | 86 | 60 | 49% (42) | None | $1,539 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Methenamine Hippurate | 19 | $1,228 | $65 |
| Gabapentin | 39 | $305 | $8 |
| Oxycodone | 26 | $90 | $3 |
| Ibuprofen | 23 | $88 | $4 |
| Tramadol | 25 | $67 | $3 |
| Cephalexin | 15 | $65 | $4 |
2022: 5 drugs
| Gabapentin | 31 | $311 | $10 |
| Oxycodone | 18 | $117 | $7 |
| Ibuprofen | 18 | $96 | $5 |
| Cephalexin | 20 | $94 | $5 |
| Tramadol | 21 | $73 | $3 |
2021: 4 drugs
| Cephalexin | 20 | $172 | $9 |
| Oxycodone | 22 | $149 | $7 |
| Gabapentin | 13 | $123 | $9 |
| Tramadol | 15 | $35 | $2 |
2020: 3 drugs
| Oxycodone | 13 | $88 | $7 |
| Tramadol | 24 | $50 | $2 |
| Sulfamethoxazole-Trimethoprim | 14 | $36 | $3 |
2019: 2 drugs
| Tramadol | 26 | $67 | $3 |
| Oxycodone | 12 | $59 | $5 |
Money from drug and device companies
$144 in 2024
A payment is not proof that care is biased.
| Boston Scientific | Ams 700 | $144 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2024-03-06 | Ams 700 | $144 |
Professional record
- NPI
- 1922576420
- Licence
- CA 95010205
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 3 Blu Harbor Blvd, Unit 253, Redwood City, CA, 94063
- NPI first listed
- 2018-11-02
- NPI last updated
- 2019-02-06
This is when the NPI record was last certified, not a medical board exam.